BDBM620503 N-(6-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole-5-carbonyl)-N-(2-(6-fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole-5-carboxamido)ethyl)glycine::US11767332, Example 9

SMILES OB1OCc2cc(C(=O)NCCN(CC(O)=O)C(=O)c3cc4COB(O)c4cc3F)c(F)cc12

InChI Key InChIKey=AVXAWRYJOASUAO-UHFFFAOYSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 620503   

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620503(N-(6-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  2.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620503(N-(6-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  6.79E+7nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent